These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21536181)

  • 1. [Treatment of pulmonary arterial hypertension in 2011: what's new since the 2009 ERS/ESC guidelines?].
    Savale L; Jaïs X; Montani D; Sitbon O; Simonneau G; Humbert M
    Presse Med; 2011 Apr; 40 Suppl 1():1S54-60. PubMed ID: 21536181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic algorithms in pulmonary hypertension in the light of current guidelines].
    Okutucu S; Tokgözoğlu L
    Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():19-26. PubMed ID: 20819752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current treatment strategies for pulmonary arterial hypertension.
    Lee SH; Rubin LJ
    J Intern Med; 2005 Sep; 258(3):199-215. PubMed ID: 16115293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current therapeutics and practical management strategies for pulmonary arterial hypertension.
    Agarwal R; Gomberg-Maitland M
    Am Heart J; 2011 Aug; 162(2):201-13. PubMed ID: 21835279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future therapeutic targets for pulmonary arterial hypertension.
    Fraidenburg D; Yuan J
    High Alt Med Biol; 2013 Jun; 14(2):134-43. PubMed ID: 23795733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapies in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
    Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre.
    Montani D; O'Callaghan DS; Jaïs X; Savale L; Natali D; Redzepi A; Hoette S; Parent F; Sitbon O; Simonneau G; Humbert M
    Eur Respir Rev; 2009 Dec; 18(114):272-90. PubMed ID: 20956152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future.
    Malenfant S; Margaillan G; Loehr JE; Bonnet S; Provencher S
    Expert Rev Respir Med; 2013 Feb; 7(1):43-55. PubMed ID: 23362814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the use of combination targeted therapeutic approaches for the management of pulmonary arterial hypertension.
    O'Callaghan DS; Savale L; Jaïs X; Natali D; Montani D; Humbert M; Simonneau G; Sitbon O
    Respir Med; 2010 Jul; 104 Suppl 1():S74-80. PubMed ID: 20418081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2009 ESC/ERS pulmonary hypertension guidelines and connective tissue disease.
    Nakanishi N; ;
    Allergol Int; 2011 Dec; 60(4):419-24. PubMed ID: 22015568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging treatments for pulmonary arterial hypertension.
    O'Callaghan DS
    Clin Respir J; 2008 Jul; 2(3):132-40. PubMed ID: 20298321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic approaches for pulmonary arterial hypertension: Unique molecular targets to site-specific drug delivery.
    Vaidya B; Gupta V
    J Control Release; 2015 Aug; 211():118-33. PubMed ID: 26036906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Update on the Management of Pulmonary Arterial Hypertension and the Pharmacist's Role.
    Macaulay TE; Covell MB; Pogue KT
    J Pharm Pract; 2016 Feb; 29(1):67-76. PubMed ID: 26614770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update.
    Johnson SG; Kayser SR; Attridge RL; Duvall L; Kiser TH; Moote R; Reed BN; Rodgers JE; Erstad B
    Pharmacotherapy; 2012 Jun; 32(6):e134-69. PubMed ID: 22467427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of platelet-derived growth factor signaling in pulmonary arterial hypertension.
    Berghausen E; ten Freyhaus H; Rosenkranz S
    Handb Exp Pharmacol; 2013; 218():381-408. PubMed ID: 24092349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances and future perspectives in therapeutic strategies for pulmonary arterial hypertension.
    Yao A
    J Cardiol; 2012 Nov; 60(5):344-9. PubMed ID: 23068290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of dyspnea in advanced pulmonary arterial hypertension.
    Sajkov D; Petrovsky N; Palange P
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and advancing treatments for pulmonary arterial hypertension in childhood.
    Zijlstra WM; Ploegstra MJ; Berger RM
    Expert Rev Respir Med; 2014 Oct; 8(5):615-28. PubMed ID: 25047735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.